Open access · OA via Europe PMC

Inflammatory and Epigenetic Biomarkers in Prostate Disease: Current Evidence, Clinical Limitations, and Future Multimarker Strategies

Donath-Miklos I, Popețiu R, Crișan A, Vulciu P, Știrbu O, Coman R, Avram C, Goldiș D, Roman D, Chioreanu A, Bugari R, Zdremțan D, Borta S.

Diagnostics (Basel, Switzerland) · 2026

Epigenetic alterations Chronic inflammation Human

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: Europe PMC
Canonical: link ↗
Fetched: 2026-07-01 MST

Cite this

APA

I, D., R, P., A, C., P, V., O, �., R, C., C, A., D, G., D, R., A, C., R, B., D, Z., & S., B. (2026). Inflammatory and Epigenetic Biomarkers in Prostate Disease: Current Evidence, Clinical Limitations, and Future Multimarker Strategies. <em>Diagnostics (Basel, Switzerland)</em>. https://europepmc.org/article/PMC/PMC13298452

Vancouver

I D, R P, A C, P V, O �, R C, et al. Inflammatory and Epigenetic Biomarkers in Prostate Disease: Current Evidence, Clinical Limitations, and Future Multimarker Strategies. Diagnostics (Basel, Switzerland). 2026.

BibTeX

@article{donathmiklos2026Inflam, title = {Inflammatory and Epigenetic Biomarkers in Prostate Disease: Current Evidence, Clinical Limitations, and Future Multimarker Strategies}, author = {Donath-Miklos I and Popețiu R and Crișan A and Vulciu P and Știrbu O and Coman R and Avram C and Goldiș D and Roman D and Chioreanu A and Bugari R and Zdremțan D and Borta S.}, journal = {Diagnostics (Basel, Switzerland)}, year = {2026}, }